In a cross-sectional study, researchers compared COVID-19 infection and mortality rates from 2019 and 2020 among Medicare enrollees with Alzheimer disease and related dementias.
Acadia Pharmaceuticals resubmitted the sNDA after addressing issues raised in a Complete Response Letter issued by the Agency.
Jiu-Chiuan Chen, MD, ScD and Diana Younan, PhD, MPH discuss the importance of understanding the relationship between air pollution and dementia risk and how clinicians can help patients mitigate their risk.
Researchers sought to determine the association of loneliness with 10-year all-cause dementia risk and the cross-sectional association of loneliness with early markers of Alzheimer disease and related dementia vulnerability.
The link between head injury and dementia risk is not straightforward, but a neurologist and neuropsychologist discuss potential mechanisms and prevention efforts that can help increase awareness and minimize cognitive problems.
A team of researchers assessed COVID-19 outcomes in patients with neurodegenerative diseases compared with patients without such disease.
Hyperuricemia and gout may be associated with a lower risk for Alzheimer disease.
The researchers sought to understand the prognostic value of tau positron emission tomography for predicting cognitive decline across the clinical spectrum of Alzheimer disease.
The researchers’ objective was to assess the neuroimaging features of patients with cerebral amyloid angiopathy, or CAA, with and without objective memory impairment using tau PET imaging.
While sleep dysregulation is a feature of dementia, it remains unclear whether the duration of sleep prior to old age is associated with dementia. The researchers examined the association between sleep duration and incidence of dementia using a 25-year follow-up.
